
U S Physical Therapy Inc
USPHNYSECIK 885978HealthcareFiscal year ends Dec 31
Reports and events: 523 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-11-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-045836 |
| 2024-11-0616:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000062 |
| 2024-11-0116:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events | 0000885978-24-000059 |
| 2024-10-0716:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000056 |
| 2024-09-0316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000054 |
| 2024-08-2116:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000052 |
| 2024-08-1616:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000050 |
| 2024-08-1416:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001140361-24-037313 |
| 2024-08-1416:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000048 |
| 2024-07-0314:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000045 |
| 2024-06-0516:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000043 |
| 2024-05-3116:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-24-000041 |
| 2024-05-3016:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000036 |
| 2024-05-2116:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000885978-24-000033 |
| 2024-05-0916:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000031 |
| 2024-05-0916:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000030 |
| 2024-05-0817:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-024976 |
| 2024-05-0717:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000026 |
| 2024-05-0613:38 ET | 8-K | 8.01 Other events | 0000885978-24-000024 |
| 2024-05-0216:06 ET | 8-K | 8.01 Other events | 0000885978-24-000022 |
| 2024-05-0116:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000020 |
| 2024-04-1517:05 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0001140361-24-019890 |
| 2024-04-0216:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000018 |
| 2024-03-1116:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000015 |
| 2024-03-1117:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000013 |
| 2024-03-0716:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-24-000011 |
| 2024-03-0116:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000007 |
| 2024-02-2916:35 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-010454 |
| 2024-02-2816:53 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000005 |
| 2024-01-0908:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000002 |
| 2023-11-0916:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-23-000044 |
| 2023-11-0816:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001140361-23-052081 |
| 2023-11-0817:57 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000041 |
| 2023-11-0116:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000039 |
| 2023-10-0217:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000037 |
| 2023-08-2216:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-23-000034 |
| 2023-08-1616:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-23-000032 |
| 2023-08-0915:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001140361-23-038777 |
| 2023-08-0910:34 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000029 |
| 2023-08-0116:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000026 |
| 2023-07-0708:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-23-000024 |
| 2023-05-3116:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000021 |
| 2023-05-3016:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-23-000019 |
| 2023-05-2517:26 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-026687 |
| 2023-05-1717:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-025301 |
| 2023-05-1110:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-024033 |
| 2023-05-0516:16 ET | 8-K | 7.01 Regulation FD disclosure | 0000885978-23-000017 |
| 2023-05-0516:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001140361-23-023184 |
| 2023-05-0515:39 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-23-000015 |
| 2023-04-1009:51 ET | DEF 14A | Proxy statement | 0001140361-23-017433 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.